A Phase 1, Randomized, Double Blind (Sponsor Open), Placebo Controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf 06260414 In Healthy Western And Japanese Male Subjects

Trial Profile

A Phase 1, Randomized, Double Blind (Sponsor Open), Placebo Controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf 06260414 In Healthy Western And Japanese Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2016

At a glance

  • Drugs PF 626414 (Primary)
  • Indications Cachexia
  • Focus Adverse reactions; First in man
  • Sponsors Pfizer
  • Most Recent Events

    • 13 Apr 2016 Results published in the Clinical Therapeutics
    • 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 16 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top